News
Senhwa Biosciences begins patient dosing in NCI-sponsored pilot study of Pidnarulex pharmacodynamics in patients with advanced solid tumours: Taipei, Taiwan Thursday, July 17, 202 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback